Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideGILDGilead Sciences
FinDog View：Neutral
TMOThermo Fisher Scientific
FinDog View：Bullish
| Metric | GILD | TMO |
|---|
| Close | 147.68 | 648.43 |
| Market Cap | $183B | $240B |
| 1M | +6.31% | +10.75% |
| P/E (TTM) | — | 34.4 |
| Forward P/E | 25.3 | 21.8 |
| P/E 5-Yr Percentile | — | 65 |
| P/S | 6.0 | 5.2 |
| P/B | 15.3 | 4.6 |
| Dividend Yield | 3.98% | 0.29% |
| Latest Quarter Revenue | $7.8B | $12.0B |
| Revenue YoY | +10.2% | +10.5% |
| Gross Margin | 79.8% | — |
| Latest Quarter EPS | -8.45 | 4.68 |
| Avg Post-Earnings Move | ±3.8% | ±1.2% |
| EPS Beat Rate | — | — |
| Guidance Hit Rate | — | — |
| Shareholder Yield | 3.01% | 2.36% |
| 90-Day Net Insider Buying | −$15.4M | −$38.9M |
GILD · Revenue, Last 8 Quarters ($B)
TMO · Revenue, Last 8 Quarters ($B)
